Big changes are afoot in the availability of compounded drugs. The Drug Quality and Security Act (DQSA) set the stage for these changes, but the FDA is going farther in implementing them. The biggest threat is to "office use" - the ability of NDs to obtain compounded drugs in quantity for in-office administration - versus needing to write a patient specific prescription. As these changes take effect, some compounded meds (and associated supplies) may become scarce or cost more to obtain.
What can you do to prepare? For a start, register
for the next AANP State Alliance webinar, to be held Monday, December 15 from 7-8 pm ET. In this program, leaders from AANP and the compounding pharmacy profession will walk you through what the law says...what the FDA has done so far and is planning to do...what AANP and other organizations have pushed back with...and what the upshot is for your practice.
Be "in the know" should the FDA come knocking on your door – and ready for the likely market changes. To register, click here.